Lentivirus delivery by adsorption to tissue engineering scaffolds

Journal of Biomedical Materials Research - Part A

Volumn 93, Issue 4, 2010, Pages 1252-1259

  Shin, Seungjin ^a   Salvay, David M ^a   Shea, Lonnie D ^a,b  

^a Northwestern University   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Extracellular matrix; Lentivirus; PLG; Surface immobilization; Tissue engineering scaffold

Indexed keywords

BIOMATERIAL SCAFFOLDS; EXTRACELLULAR MATRICES; GENE DELIVERY SYSTEMS; IN-VITRO; IN-VIVO; LENTIVIRAL VECTOR; LOCALIZED GENE DELIVERY; MODEL SYSTEM; POLY LACTIDE-CO-GLYCOLIDE; POROUS TISSUE; REGENERATIVE MEDICINE; SURFACE IMMOBILIZATION; THERAPEUTIC APPLICATION; TISSUE ENGINEERING APPLICATIONS; TISSUE ENGINEERING SCAFFOLD; TISSUE FORMATION; TRANSGENE EXPRESSION;

ADSORPTION; ENGINEERING; FREEZING; GENE TRANSFER; KNOWLEDGE ENGINEERING; SUGAR (SUCROSE); TISSUE; TISSUE ENGINEERING; VIRUSES;

SCAFFOLDS;

COLLAGEN; FIBRONECTIN; LENTIVIRUS VECTOR; POLYGLACTIN; SUCROSE; TISSUE SCAFFOLD;

ADENOVIRUS; ADSORPTION KINETICS; ANIMAL CELL; ARTICLE; CONTROLLED STUDY; FREEZE DRYING; IMMOBILIZATION; IN VIVO GENE TRANSFER; LENTIVIRINAE; MALE; MOUSE; NONHUMAN; PROTEIN BINDING; TISSUE ENGINEERING; VECTOR CONTROL; VIRAL GENE DELIVERY SYSTEM; VIRUS ATTACHMENT;

ADSORPTION; ANIMALS; COLLAGEN; FIBRONECTINS; FREEZE DRYING; FREEZING; GENE TRANSFER TECHNIQUES; GREEN FLUORESCENT PROTEINS; HUMANS; LENTIVIRUS; LUMINESCENCE; MALE; MICE; POLYMERS; SUCROSE; TISSUE ENGINEERING; TISSUE SCAFFOLDS;

EID: 77951611370     PISSN: 15493296     EISSN: 15524965     Source Type: Journal    
DOI: 10.1002/jbm.a.32619     Document Type: Article

References (33)

1. Jang JH, Rives CB, Shea LD. Plasmid delivery in vivo from porous tissue-engineering scaffolds: Transgene expression and cellular transfection. Mol Ther 2005;12:475-483.
2. De Laporte L, Shea LD. Matrices and scaffolds for DNA delivery in tissue engineering. Adv Drug Deliv Rev 2007;59:292-307. (Pubitemid 46879971)
3. Huang YC, Simmons C, Kaigler D, Rice KG, Mooney DJ. Bone regeneration in a rat cranial defect with delivery of PEI-condensed plasmid DNA encoding for bone morphogenetic protein-4 (BMP-4). Gene Ther 2005;12:418-1416
4. Trentin D, Hall H, Wechsler S, Hubbell JA. Peptide-matrix-mediated gene transfer of an oxygen-insensitive hypoxia-inducible factor-1alpha variant for local induction of angiogenesis. Proc Natl Acad Sci USA 2006;103:2506-2511. (Pubitemid 43306579)
5. Phillips JE, Burns KL, Le Doux JM, Guldberg RE, Garcia AJ. Engineering graded tissue interfaces. Proc Natl Acad Sci USA 2008;105:12170-12175.
6. Cheema SK, Chen E, Shea LD, Mathur AB. Regulation and guidance of cell behavior for tissue regeneration via the siRNA mechanism. Wound Repair Regen 2007;15:286-295. (Pubitemid 46817403)
7. Whittlesey KJ, Shea LD. Nerve growth factor expression by PLG-mediated lipofection. Biomaterials 2006;27:2477-2486. (Pubitemid 41821826)
8. Huang YC, Riddle K, Rice KG, Mooney DJ. Long-term in vivo gene expression via delivery of PEI-DNA condensates from porous polymer scaffolds. Hum Gene Ther 2005;16:609-617. (Pubitemid 40740928)
9. Jang JH, Bengali Z, Houchin TL, Shea LD. Surface adsorption of DNA to tissue engineering scaffolds for efficient gene delivery. J Biomed Mater Res A 2006;77:50-58.
10. Rives CB, des Rieux A, Zelivyanskaya M, Stock SR, Lowe WL, Jr., Shea LD. Layered PLG scaffolds for in vivo plasmid delivery. Biomaterials 2009;30:394-401.
11. De Laporte L, Cruz Rea J, Shea LD. Design of modular nonviral gene therapy vectors. Biomaterials 2006;27:947-954. (Pubitemid 41566686)
12. Bengali Z, Pannier AK, Segura T, Anderson BC, Jang JH, Mustoe TA, Shea LD. Gene delivery through cell culture substrate adsorbed DNA complexes. Biotechnol Bioeng 2005;90:290-302. (Pubitemid 40779206)
13. Bengali Z, Rea JC, Gibly RF, Shea LD. Efficacy of immobilized polyplexes and lipoplexes for substrate-mediated gene delivery. Biotechnol Bioeng 2009;30:2361-2368.
14. Pannier AK, Anderson BC, Shea LD. Substrate-mediated delivery from self-assembled monolayers: Effect of surface ionization, hydrophilicity, and patterning. Acta Biomater 2005;1:511-522.
15. Hu WW, Wang Z, Hollister SJ, Krebsbach PH. Localized viral vector delivery to enhance in situ regenerative gene therapy. Gene Ther 2007;14:891-901. (Pubitemid 46780072)
16. Hu WW, Lang MW, Krebsbach PH. Development of adenovirus immobilization strategies for in situ gene therapy. J Gene Med 2008;10:1102-1112.
17. Levy RJ, Song C, Tallapragada S, DeFelice S, Hinson JT, Vyavahare N, Connolly J, Ryan K, Li Q. Localized adenovirus gene delivery using antiviral IgG complexation. Gene Ther 2001;8:659-667. (Pubitemid 32496428)
18. Fishbein I, Alferiev I, Bakay M, Stachelek SJ, Sobolewski P, Lai M, Choi H, Chen IW, Levy RJ. Local delivery of gene vectors from bare-metal stents by use of a biodegradable synthetic complex inhibits in-stent restenosis in rat carotid arteries. Circulation 2008;117:2096-2103. (Pubitemid 351572181)
19. Jewell CM, Lynn DM. Multilayered polyelectrolyte assemblies as platforms for the delivery of DNA and other nucleic acid-based therapeutics. Adv Drug Deliv Rev 2008;60:979-999.
20. Segura T, Anderson BC, Chung PH, Webber RE, Shull KR, Shea LD. Crosslinked hyaluronic acid hydrogels: A strategy to functionalize and pattern. Biomaterials 2005;26: 359-371. (Pubitemid 38951103)
21. Jin X, Mei L, Song C, Liu L, Leng X, Sun H, Kong D, Levy RJ. Immobilization of plasmid DNA on an anti-DNA antibody modified coronary stent for intravascular site-specific gene therapy. J Gene Med 2008;10:421-429. (Pubitemid 351517098)
22. Bennett J. Immune response following intraocular delivery of recombinant viral vectors. Gene Ther 2003;10:977-982. (Pubitemid 36722432)
23. Salvay DM, Rives CB, Zhang X, Chen F, Kaufman DB, Lowe WL, Jr., Shea LD. Extracellular matrix protein-coated scaffolds promote the reversal of diabetes after extrahepatic islet transplantation. Transplantation 2008;85:1456-1464.
24. Laporte LD, Yang Y, Zelivyanskaya ML, Cummings BJ, Anderson AJ, Shea LD. Plasmid releasing multiple channel bridges for transgene expression after spinal cord injury. Mol Ther 2008.
25. Dull T, Zufferey R, Kelly M, Mandel RJ, Nguyen M, Trono D, Naldini L. A third-generation lentivirus vector with a conditional packaging system. J Virol 1998;72:8463-8471. (Pubitemid 28471781)
26. Bondi A, Chieregatti G, Eusebi V, Fulcheri E, Bussolati G. The use of beta-galactosidase as a tracer in immunocytochemistry. Histochemistry 1982;76:153-158.
27. De Laporte L, Lei Yan A, Shea LD. Local gene delivery from ECM-coated poly(lactide-co-glycolide) multiple channel bridges after spinal cord injury. Biomaterials 2009;30:2361-2368.
28. Uhlenhaut C, Dorner T, Pauli G, Pruss A. Effects of lyophilization on the infectivity of enveloped and non-enveloped viruses in bone tissue. Biomaterials 2005;26:6558-6564. (Pubitemid 41021749)
29. Croyle MA, Cheng X, Wilson JM. Development of formulations that enhance physical stability of viral vectors for gene therapy. Gene Ther 2001;8:1281-1290. (Pubitemid 32834296)
30. Bajaj B, Lei P, Andreadis ST. High efficiencies of gene transfer with immobilized recombinant retrovirus: Kinetics and optimization. Biotechnol Prog 2001;17:587-596. (Pubitemid 32748045)
31. Bengali Z, Rea JC, Shea LD. Gene expression and internalization following vector adsorption to immobilized proteins: Dependence on protein identity and density. J Gene Med 2007;9:668-678. (Pubitemid 47288825)
32. Parrott MB, Adams KE, Mercier GT, Mok H, Campos SK, Barry MA. Metabolically biotinylated adenovirus for cell targeting, ligand screening, and vector purification. Mol Ther 2003;8:688-700. (Pubitemid 37321698)
33. Riddle KW, Kong HJ, Leach JK, Fischbach C, Cheung C, Anseth KS, Mooney DJ. Modifying the proliferative state of target cells to control DNA expression and identifying cell types transfected in vivo. Mol Ther 2007;15:361-368. (Pubitemid 46111887)